'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
<p>Abstract</p> <p>Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients. These, data together with the observations of dimi...
Main Authors: | Shantsila Eduard, Lip Gregory YH |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-08-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/6/1/47 |
Similar Items
-
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
by: Eduard Shantsila, et al.
Published: (2016-02-01) -
Emerging Tools for Stroke Prevention in Atrial Fibrillation
by: Christos Voukalis, et al.
Published: (2016-02-01) -
PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01) -
Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients
by: Reeves Mathew, et al.
Published: (2008-08-01) -
Which people should take aspirin for primary prevention of cardiovascular disease?
by: Lozano R, et al.
Published: (2015-07-01)